ELDN Eledon Pharmaceuticals


Data from SEC filings
Employee count

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

Eledon Pharmaceuticals, Inc. (the “Company”) held its annual meeting of stockholders on June 15, 2021 (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted in the following manner with respect to the following proposals:

1.The election of three Class I directors, each to serve for a three-year term expiring at the 2024 annual meeting of stockholders and until his or her successor has been duly elected and qualified.

NomineesForWithholdBroker Non- Votes
June Lee, M.D.8,444,2408,724 844,399
Walter Ogier8,443,0649,900 844,399
Steven Perrin, Ph.D.8,435,71917,245 844,399

2.The ratification of the appointment of KMJ Korbin & Company LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021.